🔎 Trials Near Me

ホーム › 急性骨髄性白血病 › ジョージア州 › Atlanta

Atlanta、GAにおける急性骨髄性白血病の臨床試験

Atlantaとその周辺地域(約30マイル以内)の拠点で、急性骨髄性白血病に関する31件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト(英語)

ここで研究参加者を募集していますか? このページの上部に表示できます — 30日間 $99 →

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

被験者募集中第1相
  • Children'S Healthcare Of Atlanta - Arthur M. Blank Hospital /ID# 275740, Atlanta
6 Months – 17 Years · 全性別 · 2026/10/05更新 · NCT07306832

Ivosidenib as Post-HSCT Maintenance for AML

被験者募集中第2相
  • Emory University Hospital, Atlanta
18歳〜75歳 · 全性別 · 2026/10/05更新 · NCT06707493

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

被験者募集中第1相
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
21歳以下 · 全性別 · 2026/10/05更新 · NCT07012044

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

被験者募集中観察研究健康なボランティア歓迎
  • Atlanta VA Medical Center, Decatur · 6マイル先
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

被験者募集中観察研究
  • Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta
0歳〜38歳 · 全性別 · 2026/10/01更新 · NCT06131801

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

被験者募集中第1相
  • Emory University Hospital/Winship Cancer Institute, Atlanta
18歳以上 · 全性別 · 2026/10/01更新 · NCT06484062

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

被験者募集中第1相
  • Emory University, Atlanta
12歳〜78歳 · 全性別 · 2026/09/29更新 · NCT03802695

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

被験者募集中第3相
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
6 Months – 21 Years · 全性別 · 2026/09/17更新 · NCT04293562

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

被験者募集中第1/2相
  • Emory Winship Cancer Institute, Atlanta
30 Days · 全性別 · 2026/09/16更新 · NCT04065399

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

被験者募集中第2相
  • Winship Cancer Institute - Emory University, Atlanta
18歳以上 · 全性別 · 2026/09/15更新 · NCT04996875

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

被験者募集中第3相
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
1歳〜25歳 · 全性別 · 2026/09/04更新 · NCT07022678

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

被験者募集中第3相
  • US-Atlanta GA-EMORY, Atlanta
18歳以上 · 全性別 · 2026/09/02更新 · NCT06652438

Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

被験者募集中第3相
  • US-Atlanta GA-EMORY, Atlanta
18歳以上 · 全性別 · 2026/09/01更新 · NCT07223814

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

被験者募集中第3相
  • Children's Healthcare of Atlanta, Atlanta
29 Days – 21 Years · 全性別 · 2026/08/24更新 · NCT05183035

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

被験者募集中第1相
  • Emory Healthcare - The Emory Clinic, Atlanta
18歳以上 · 全性別 · 2026/08/20更新 · NCT06001788

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

被験者募集中第1相
  • Children's Healthcare of Atlanta, Atlanta
1歳〜30歳 · 全性別 · 2026/08/03更新 · NCT06177067

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

被験者募集中第1相健康なボランティア歓迎
  • Northside Hospital, Atlanta
18歳〜75歳 · 全性別 · 2026/07/28更新 · NCT07020533

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

被験者募集中第3相
  • Emory University - Winship Cancer Institute (WCI), Atlanta
18歳〜75歳 · 全性別 · 2026/07/17更新 · NCT05429632

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

被験者募集中観察研究
  • Children's Healthcare of Atlanta, Atlanta
  • Northside Hospital, Atlanta
全年齢 · 全性別 · 2026/07/06更新 · NCT01351545

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

被験者募集中第1/2相
  • Emory Winship Cancer Institute, Atlanta
18歳以上 · 全性別 · 2026/06/24更新 · NCT04068597

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

被験者募集中第1相
  • Winship Cancer Institute / Emory University, Atlanta
18歳以上 · 全性別 · 2026/06/15更新 · NCT05768932

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

被験者募集中第2/3相
  • University of Emory - Winship Cancer Institute, Atlanta
18歳以上 · 全性別 · 2026/04/30更新 · NCT04256317

Pilot Imaging Study of Leukemia

被験者募集中第1相
  • Emory University, Atlanta
4歳〜80歳 · 全性別 · 2026/04/23更新 · NCT03633955

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

被験者募集中第1相
  • Emory Healthcare - The Emory Clinic, Atlanta
18歳以上 · 全性別 · 2026/03/13更新 · NCT05735184

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

被験者募集中第2相健康なボランティア歓迎
  • Northside Hospital, Atlanta
18歳〜75歳 · 全性別 · 2026/03/10更新 · NCT06059391

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

被験者募集中第1相
  • Emory University Hospital, Atlanta
18歳以上 · 全性別 · 2026/01/16更新 · NCT05143996

Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL

被験者募集中第1相
  • Emory University - WINSHIP Cancer Center, Atlanta
  • Emory University, Children's Healthcare of Atlanta, Atlanta
12歳以上 · 全性別 · 2026/01/08更新 · NCT04872478

Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia

被験者募集中第1相
  • Blood and Marrow Transplant Group of Georgia, Atlanta
18歳以上 · 全性別 · 2025/10/31更新 · NCT06549790

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

被験者募集中健康なボランティア歓迎
  • Emory University, Atlanta
18歳〜120歳 · 全性別 · 2025/07/25更新 · NCT05237258

他の都市における急性骨髄性白血病の試験

Atlantaにおける他の研究

ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。